In the United States, about 26.5% of adults with diagnosed diabetes were using a GLP-1 injectable medication in 2024, highlighting how central these treatments have become in modern diabetes and weight management
During early growth (until about the second year after birth), about 1020% of the amino acid pool is used in growth and is thus not available for GSH synthesis and one-carbon metabolism [7577]
Some manufacturers are exploring Liquid Phase Peptide Synthesis (LPPS) or hybrid approaches to improve throughput, but these transitions require significant re-validation and regulatory oversight
Nevertheless, diabetes specialists and ophthalmologists may want to monitor patients carefully for visual symptoms
Participants were randomized to once-weekly subcutaneous retatrutide 1 mg (n = 20), 4 mg (n = 19), 8 mg (n = 22), 12 mg (n = 18) or placebo (n = 19)